Trial intelligence / Profile preview

Liuwei Anshen Capsule for perimenopausal insomnia

ChiCTR2200064557Phase 4Not yet recruiting

Sponsor
Hubei University of Chinese Medicine
Start
Oct 2022
Countries
1
01

Overview

Phase 4 trial of liuwei anshen in Insomnia and climacteric (2 arms), sponsored by Hubei University of Chinese Medicine. Primary endpoints: Pittsburgh Sleep Quality Index and polysomnography. Planned start Oct 2022; status: not yet recruiting.

02

Drugs

liuwei anshen
03

Conditions

Insomniaclimacteric

Beyond the preview

Go deeper on ChiCTR2200064557.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200064557.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call